chr11-113909368-A-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_006028.5(HTR3B):c.126A>T(p.Lys42Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_006028.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTR3B | NM_006028.5 | c.126A>T | p.Lys42Asn | missense_variant | 2/9 | ENST00000260191.8 | NP_006019.1 | |
HTR3B | NM_001363563.2 | c.93A>T | p.Lys31Asn | missense_variant | 1/8 | NP_001350492.1 | ||
HTR3B | XM_047427869.1 | c.93A>T | p.Lys31Asn | missense_variant | 1/6 | XP_047283825.1 | ||
HTR3B | XM_024448767.2 | c.-169A>T | 5_prime_UTR_variant | 2/9 | XP_024304535.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HTR3B | ENST00000260191.8 | c.126A>T | p.Lys42Asn | missense_variant | 2/9 | 1 | NM_006028.5 | ENSP00000260191.2 | ||
HTR3B | ENST00000537778.5 | c.93A>T | p.Lys31Asn | missense_variant | 1/8 | 1 | ENSP00000443118.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152210Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461360Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727006
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at